Catherine Hye-Won Han

7PUBLICATIONS
30CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)Cultural theoryHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 13, 2026
Early ctDNA Dynamics Predict Response to Mosperafenib in BRAF V600-Mutant Metastatic Colorectal Cancer.

|Apr 30, 2026
Evaluating Oxaliplatin Exposure in Adults with Advanced Colorectal Cancer: Development and Validation of Methods with Enhanced Bioanalytical Specificity and Clinical Applicability.

|Mar 27, 2026
Phase I Study of Mosperafenib, a Novel Paradox Breaker B-Raf Proto-Oncogene Serine/Threonine Kinase (BRAF) Inhibitor, in Patients With BRAF V600-Mutant Solid Tumors.

Maria Vieito, Elisa Fontana, Catherine H Han

|Mar 26, 2025
Contemporary Patterns of Care for Low-Grade Glioma in Australia and New Zealand.

Meghana Maddula, Nicholas McNamee, Hui K Gan

|Dec 27, 2023
Exploring the Important Determinants Shaping Treatment Preferences: Qualitative Insights into Breast Cancer Patient Experiences and Perspectives in New Zealand.

Hui Yee Yeo, Jacqueline Hui Yi Wong, Suz Jack Chan

|Nov 06, 2023
Understanding Patient Preferences Regarding the Important Determinants of Breast Cancer Treatment: A Narrative Scoping Review.

Hui Yee Yeo, Ai Ch'i Liew, Suz Jack Chan

Pageof 2

Frequent Collaborators

2 joint publications

Hui Yee Yeo

2 joint publications

Mudassir Anwar

2 joint publications

Carlo A Marra

2 joint publications

Irene Moreno